Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

40.86
Delayed Data
As of Oct 16
 -0.15 / -0.37%
Today’s Change
37.20
Today|||52-Week Range
44.54
+6.10%
Year-to-Date

Today’s Trading

Previous close41.01
Today’s open40.94
Day’s range40.64 - 41.00
Volume4,132,566
Average volume (3 months)2,914,180
Market cap$100.9B
Dividend yield6.10%
Data as of 10/16/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+15.06%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+2.85%
P/E ratio51.9
Price/Sales2.52
Price/Book71.86

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-1.64-2.51%
NVONovo Nordisk+1.79+3.77%
LLYEli Lilly and Co-0.60-0.69%
CELGCelgene+0.25+0.18%
Data as of 10/16/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)$0.84
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts